The main causes for mid-trimester loss are known. There is likely to be overlap with those of first trimester loss, but the proportions may be different. We wished to perform an aetiological survey in a large population of patients with a history of recurrent miscarriage, for possible explanations for their second trimester miscarriages. Database analysis of 636 patients attending a UK University Teaching Hospital dedicated miscarriage clinic between 1991 and 1996 revealed a 25% prevalence (n ⍧ 158) for second trimester miscarriage. Results from an investigative screening protocol were positive in 50% of cases: 33% (n ⍧ 52) tested positive for antiphospholipid syndrome (APS); 8% (n ⍧ 13) fulfilled strict criteria for cervical incompetence; there was a 4% prevalence of uterine anomaly; 3% for infection (n ⍧ 5) and 2% of patients (n ⍧ 3) proved to be hypothyroid. Importantly, dual pathology was found in 5% of patients with a history of second trimester miscarriage. As idiopathic mid-trimester loss is a diagnosis by exclusion, a high index of suspicion is required, as are modern diagnostic techniques.
Introduction
Recurrent pregnancy loss still holds a lot of unanswered questions. On reviewing the literature, there has been very little published specifically on second trimester miscarriage as a separate subgroup. In 1996, Flint and Gibb reviewed midtrimester loss and stated that there is likely to be an overlap with the causes of first trimester loss but the proportions may be different. Mid-trimester loss is defined as pregnancy loss between 12 and 24 weeks gestation.
Malpas in 1938 wrote that repeated miscarriage may be caused by 'some condition inimical to the growth of the fetus recurring in each pregnancy'. Historically, analysis of cause seldom revealed explanations for these losses. In modern practice, conditions and diseases are known to contribute to second trimester miscarriage. Pathologies may be present either in isolation or in combination with other disease processes. Patients attending a recurrent miscarriage clinic are a very heterogeneous group displaying widely varying aetiology. Thus we have reported on a large number of consecutive patients presenting to a busy miscarriage clinic over a long period of time.
There have been several informative reviews written in recent years for the management of recurrent pregnancy loss (Tables I and II) . However, most of these use more common criteria which groups together patients with all kinds of pregnancy loss. Whichever definition or criterion is used, most published data identify factors to explain the miscarriages for approximately half of cases. Stray-Pedersen and Stray-Pedersen (1988) commented that this merely reflects the lack of knowledge concerning factors involved in recurrent miscarriage and thereby the insufficiency of available diagnostic methods.
We wished to examine a live database of results from patients who had suffered a mid-trimester loss for the prevalence of pathology. In doing so, we hoped to refine our own investigative protocol and also to provide guidelines for the physician, using modern diagnostic techniques when presented with a patient who experiences second trimester miscarriages.
Materials and methods
The study comprised 656 consecutive couples referred to the Liverpool Women's Hospital between 1991 to 1996, all having had at least two spontaneous miscarriages, regardless of gestation. All were reviewed at a dedicated miscarriage clinic. The complete patient list was double checked and attendance verified from a separate out-patient appointment printout. Patient information was entered onto a spreadsheet database, with findings checked by a second doctor. Of these, 158 (25%) of couples had experienced a mid-trimester loss.
Following a second trimester miscarriage, a detailed gynaecological and medical history was taken. Cervical and vaginal swabs were taken for chlamydia, mycoplasma and bacterial vaginosis. A hysteroscopy was performed as a day case under general anaesthetic or as an out-patient, noting cervical length and resistance to Hegar dilators. Blood was taken for chromosomal abnormalities (both partners); full blood count; thyroid function; diabetes and auto-immune disease.
An antiphospholipid screen (APS) for lupus anticoagulant and anticardiolipin antibody was also taken as part of a clinical protocol previously described (Quenby and Farquharson, 1993) . For several years, we have used the laboratory at both the Royal Liverpool Hospital and Sheffield (classed as adequate by the UK National External Quality Assessment Scheme for anticardiolipin antibody assays).
To transport samples to Sheffield, blood was collected into 0.11 M sodium citrate (9 parts venous blood to 1 part anticoagulant). It was double centrifuged in the clinic to obtain platelet-poor plasma and this was frozen at -70°C. Samples were transferred to Sheffield in batches for analysis. Lupus anticoagulant (LA) was assessed by the dilute Russell viper venom test (dRVVT) with a platelet neutralization procedure as previously described (Thiagarajan et al., 1986) . Results were expressed as a ratio of the patient time to that of controls, the normal range being the mean of the control group Ϯ2 SD (0.9-1.09). Results were considered positive when the dRVVT ratio was Ͼ1.10 with a 20% correction following the addition of the platelet neutralization procedure. Immunoglobulin (Ig) G and M anticardiolipin antibodies were assayed by enzyme linked immunosorbent assay (ELISA), as described by Harris et al. (1986) . Results were classed as positive if antibody levels were Ͼ3 SD above the mean of the control group: Ͼ8 IU/ml for IgG and Ͼ5 IU/ml for IgM. Two positive results, 6 weeks apart were considered diagnostic of antiphospholipid syndrome.
As there is no agreement about the definition of cervical incompetence, as stated by the Euro-Team Early Pregnancy Protocol (Berry et al., 1995) , we used strict criteria to diagnose cervical weakness of: painless dilatation of the cervix resulting in ruptured membranes and second trimester miscarriage after 12 weeks, or early preterm delivery and also the passage, without resistance, of size nine Hegar dilator through the cervix in the non-pregnant state. Fetal death was diagnosed by ultrasound absence of fetal heart activity.
Results
Of the 636 consecutive patients attending the clinic, 158 (25%) had suffered a mid-trimester loss (mean 1.65, range 1-5). The mean maternal age was 32 years (range 20-49). In all, 58 women (37%) could be classified as primary aborters, never having had a successful pregnancy, whereas 100 (63%) had experienced a live birth prior to their miscarriages. The reproductive history of the study population was examined (Tables III and IV) . Of the group, 18% (n ϭ 28) had miscarried solely in the second trimester.
The distribution of findings ( Figure 1 ) revealed that for 50% of women (n ϭ 59), no diagnosis was made. The most commonly identified pathology was antiphospholipid syndrome (n ϭ 52, 33%). Of the parameters used to diagnose APS, a dRVVT tested positive in 35 patients (67%), IgM in 23 (44%) and IgG in 15 (29%) of cases. The distribution of positive parameters for APS (Table V) shows that the dRVVT was the sole positive test in 20 cases, IgM in 11 and IgG in four women. Various combinations were found, with four women out of the 52 (8%) testing positive for all three parameters. The patients who fulfilled the criteria used for cervical incompetence (n ϭ 13, 8%) gave histories of intrauterine fetal deaths at the time of delivery, with the absence of the fetal heart being diagnosed by sonography, although for seven couples the fetal heart was present on initial admission to hospital for at least one of their mid-trimester losses. Hysteroscopic findings of uterine abnormality revealed (n ϭ 6, 4%): three septate, two bicornuate and one multifibroid uteri. The results of swab and serum tests for infection at initial screening showed five (3%) possible associations with infection, those being: three cases of bacterial vaginosis, one of chlamydia and one of toxoplasmosis. None of the patients presenting had been histologically diagnosed as having chorioamnionitis at the time of their mid-trimester loss. Hypothyroidism (n ϭ 3, 2%) was demonstrated by a raised thyroid stimulating hormone (TSH), decreased thyroxine and free thyroxine levels beyond the limits of normal using the Royal Liverpool Hospital reference ranges.
When we examined our data for dual pathology (n ϭ 12, 5%) (Table VI) , we found that five patients showed evidence of cervical incompetence and tested positive for APS; two women had a uterine anomaly and APS; one woman had APS and hypothyroidism. There were no cases of dual pathology between the other conditions, nor were any cases of triple pathology identified.
Discussion
Overall loss of pregnancy from conception is 50%. This is largely attributed to chromosomal abnormalities, notably trisomy 16, which does not allow the embryo to grow Ͼ2 mm in length (Carp et al., 1990) . Early loss rate is between 12 and 15%. The miscarriage rate is reduced to~2% if a live fetus is identified by ultrasonography at 8 weeks gestation in a normal population (Cashner et al., 1987) . However, in an unscreened and therefore untreated recurrent miscarriage population, the pregnancy loss rate has been reported to be as high as 26% (Opsahl and Pettit, 1993) . Given that any miscarriage has great psychological impact on a couple, we felt that this subgroup was worthy of closer attention (StrayPedersen and Stray-Pedersen, 1988) .
We were initially surprised that a quarter of our group had suffered mid-trimester losses; however, Stray-Pedersen and Stray-Pedersen (1984) published work studying 195 couples, of whom 37% had second trimester miscarriages. Interestingly, in that series causes were identified in 56% of cases, 29% being cervical incompetence, with antiphospholipid syndrome being barely tested for at that time. The relative significance of pathology and reported incidence reflects both the knowledge Having taken an interest in the finding, Smith's detection rate for years 1925 to 1930 increased the reported incidence by five times. The selection process by which a couple is referred to a recurrent miscarriage clinic may explain the higher proportions of certain findings than those previously published for the general population, notably APS.
The definition of recurrent miscarriage fluctuates between two or three consecutive losses. For our study, we have chosen to include two miscarriages regardless of gestation, taking into account comments made by Stirrat (1990b) that two losses justified investigation as there was a significant rise in the risk of subsequent miscarriage. Bulletti et al. (1996) point that the modern social habit is to conceive at an older age; thus possible investigation and treatment might be initiated too late. Access to screening is proportional to the resources available. In first world medicine, it is reasonable to extend investigation to couples after two miscarriages and therefore acceptable to include them in our study. This has not resulted in a significantly lower proportion of positive findings, suggesting that the subgroup of mid-trimester loss sufferers are of high risk and worthy of investigation. Whether antiphospholipid antibodies are causative, a consequence or coincidence remains unknown but there is general agreement that the pregnant woman is particularly vulnerable to the adverse effects associated with these antibodies (Balasch et al., 1997) . The antiphospholipid syndrome, comprising lupus anticoagulant (LA) and anticardiolipin antibodies (aCL) are known to bind to negatively charged phospholipids and are regarded as markers of thrombosis (Birdstall and Pattison 1993) . Various theories exist as to how they are associated with miscarriage: binding to platelet membrane, activating release of thromboxane and subsequent platelet aggregation and thrombosis; binding to endothelial cells, inhibiting prostacyclin production or involvement with other clotting factors (Roubey and Hoffman, 1997) . It is likely that APS is a family of autoantibodies. A high index of suspicion is needed in any patient with an unexplained intrauterine death (Lubbe et al., 1984) , especially if associated with thrombocytopenia and arterial or venous thromboses. APS is associated with miscarriage in any trimester. Rai et al. reported (1995a) that most of their patients with APS miscarried in the first trimester. Of those, a fetal heartbeat was identified in 86% of cases. Branch et al. (1985) found that their patients with APS mostly lost in the second or early third trimester. We were at first surprised to find APS in a third of patients; however, prevalence rates of 42% have previously been reported (Unander et al., 1987) . Table V shows an interesting distribution of the parameters used to diagnose APS. The dRVVT is regarded as the gold standard investigation, and was the only positive test in 38% of cases. The dRVVT was also found in combination with the anticardiolipin antibodies. Anticardiolipin IgM was the single positive finding in 21% of cases, thus highlighting the necessity of testing for both IgM and IgG (Chamley et al., 1990) . Both LA and aCL IgM and IgG tested positive in 4% of cases. Another series on APS found that LA alone was found in 63.9% of cases of APS, IgM alone in 8.2% and all three parameters testing positive in 1.6% of patients (Rai et al., Kutteh (1996) and Rai (1996) looked at treated pregnant patients with APS, comparing low dose aspirin alone versus low dose aspirin and heparin. Both papers showed a statistically significant improvement in live birth rate for the patients treated with low dose aspirin and heparin. Both single centre studies report prospective trials, but are not comparable in study design or inclusion criteria. The trial reported by Kutteh does not use prospective random assignment to treatment and excludes patients with LA. This would exclude half the patients seen in our clinic, and in the Rai trial over half of the patients were positive for LA, although low threshold entry criteria were used, e.g. dRVVT Ͼ 1.07; aCL IgG Ͼ 5 GPL and IgM Ͼ 3 MPL. A multicentre randomized controlled trial is currently on-going and results are awaited. The emergence and importance of dual pathology in midtrimester loss has hitherto not been reported. It is important in excluding two causes, as 5% of the total population of 158 patients were found to have a combination of causes. The most common combination was cervical incompetence and antiphospholipid syndrome, two of the most treatable conditions utilizing cervical cerclage and thromboprophylaxis respectively which, in turn will provide a high success rate for intervention therapy. Clinicians should not assume, in the investigation of mid-trimester loss, that one cause would be sufficient. It is now important to exclude dual pathology.
made a valid
Before the diagnosis of cervical incompetence is made, the application of strict threshold criteria is important, as resultant management is associated with adverse sequelae. The MRC/ RCOG trial on cervical cerclage (1993) studied more than 1200 patients and concluded that cerclage is beneficial to patients with three or more pregnancies ending before 37 weeks gestation; however, whilst duration of pregnancy may be prolonged with a suture, there was no statistical difference in live birth rate. Cerclage is associated with a higher rate of medical intervention: puerperial pyrexia; use of β-sympathomimetics; hospital admissions; induction of labour and Caesarean section. In a small proportion of cases, transabdominal cervical cerclage is indicated, i.e. those with failed elective vaginal cervical suture and very short or scarred cervices. Anthony et al. (1997) reported a series of 13 patients. It took them 10 years to collect these data, given the strict criterion used, which show an 86% successful live birth rate post-procedure. This success rate is similar to Gibb and Salaria's (1995) series of 50 women published in 1995 (85.2%). We have nine successful pregnancies so far using this procedure (Topping and Farquharson 1995) . Unfortunately, these observational studies lack control groups. If delivery is by Caesarean section, the suture can be left in situ, as these women often want another child. If this is the case, Anthony et al. (1997) recommend a vertical incision in the lower segment as preferable to a classical incision, thus reducing the risk of subsequent scar rupture.
Our detection rate of uterine abnormalities was lower than other reported series. Harger et al. (1983) reported an incidence of 27% of uterine anomalies in their data set. Strassman (1966) reasoned that 'when there is only limited uterine space available, a point is reached whereby the semi-uterus is unable to expand further, resulting in miscarriage'. Uterine abnormalities can be broadly divided into two main types, those externally divided and those externally unified, though with two endometrial cavities. Other explanations for miscarriage have included implantation into an avascular septum (DeCherney et al., 1986) . The role of leiomyomata in miscarriage is also unclear. Proposed theories include that fibroids cause the uterus to become irritable, rapidly growing and degenerating, or that they alter oxytocinase activity, endometrial stroma or vasculature (Buttram and Reiter, 1981) . Modes of diagnosis for uterine anomalies have also evolved with time. Hysterosalpingogram used to be the mainstay of investigation, but is painful for the woman. Pelvic ultrasound is highly specific for uterine anomaly and is non-invasive and so suitable for screening purposes (Clifford et al., 1994) . Magnetic resonance imaging (MRI) has been proposed in the USA for the same reason, though is much more expensive (Kirk et al., 1993) . Hysteroscopy is now widely used (with laparoscopy) for directly visualizing septal defects and intrauterine synechiae. Results from metroplasty studies have claimed good success rates post-procedure from 73 to 85% (Strassman 1966; DeCherney et al., 1986; Kirk et al., 1993) ; however, as for cervical cerclage, invasive intervention is only beneficial in highly selected patients. Strassman's decription for metroplasty (1966) requires laparotomy, whereas the emergence of hysteroscopic metroplasty for septate uteri (associated with a worse prognosis than bicornuate defects) allows for minimal hospitalization. Successful hysteroscopic myomectomy for submucous fibroids up to 2 cm diameter have been described (Buttram and Reiter, 1981) . There is a need for control matched studies for live birth rate before metroplasty can be recommended. There are current plans for a multicentre randomized controlled trial for hysteroscopic metroplasty versus conservative management.
The role of infection in the aetiology of miscarriage appears to be in the second trimester rather than the first. Bacterial vaginosis (BV) is known to contribute to late fetal loss (LlahiCamp et al. 1996) . Our prevalence rate was 3%, which was lower than that of Llahi-Camp et al. (9% for a Caucasian population, higher for Afro-Caribbeans). The most sensitive and specific method to diagnose BV is by examining a Gram stain of a vaginal smear for clue cells. Ideally, this should be done in the first quarter of the menstrual cycle when levels are highest. Infrequently other pathogens will be detected with cervical swabs. Controlled trials are required to evaluate the efficacy of antibiotics for this group.
1979
Hypothyroidism was found in 2% of our group. This is lower than reported in other studies (Sandler, 1977) . When untreated, it is associated with infertility, increased fetal loss and reduced intelligence quotient in the offspring (Girling, 1996) . Stirrat (1990a) stated that as thyroid dysfunction is an uncorroborated cause of recurrent miscarriage, the value of thyroid function tests in routine evaluation is very doubtful. Clifford et al. (1994) also stated that thyroid function tests are not indicated, as they are invariably normal, and they postulated a coincidental finding in the diagnostic work-up for the recurrent miscarriage patient. It may therefore be that underactive thyroid function is an infrequent association with midtrimester loss rather than a cause.
The field of recurring miscarriage is a challenging area of medicine. We have attempted to provide investigative guidelines using modern diagnostic techniques. In spite of our socalled advancement, our overall rate of diagnosis has improved little in the last 15 years; however, the proportion of pathologies identified has changed, most noticeably antiphospholipid syndrome. The ultimate test of one's own protocol is the overall live birth rate with treatment, compared to live birth rate in women matched for the same number of miscarriages and a similar incidence of (unexplained) second trimester miscarriages. Preliminary data from the first 70 pregnancy outcomes from this group show a 67% subsequent live birth rate for the treated group, compared to 69% live birth rate for the idiopathic group. A more detailed examination of these results, together with greater patient numbers is currently ongoing. The main causes of mid-trimester loss are known and treatments are available and effective, but there is still much work to be done. The incidence of dual pathology should be remembered by the investigating team (Table VI) . At a time when obstetric care is increasingly based on sound evidence of effectiveness, it is encouraging to know that multicentre randomized controlled trials are underway for the management of two of the main causes identified for second trimester miscarriage. There is further need for prospective observation of the large idiopathic group to assess their subsequent obstetric performance and whether it is comparable to non-recurrent miscarriage groups or early recurrent miscarriage loss groups.
